NCT02997332 2026-03-23
MEDINDUCTION
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Terminated
Clinical Trials
39 trialsNCT05526924 2026-03-04
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
Phase 1 Recruiting
NCT01154920 2025-12-17
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT05758389 2025-09-05
Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Recruiting
NCT04356170 2025-09-02
TPFmORL
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed
NCT00665392 2025-08-01
ECHO-07
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Completed
NCT00544414 2025-02-19
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
City of Hope Medical Center
Phase 2 Completed
NCT03840421 2025-01-13
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Active not recruiting
NCT00868491 2024-10-18
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Institute of Oncology Ljubljana
Phase 2 Completed
NCT05358548 2024-04-10
ATATcH Alternating Treatment Plans for Advanced Cancer
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT03326947 2024-02-20
Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC
Shanghai Jiao Tong University School of Medicine
Phase 2 Recruiting
NCT02484677 2023-05-26
5-FU
Assistance Publique Hopitaux De Marseille
Phase 4 Completed
NCT00003777 2022-01-26
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT00003627 2021-02-21
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
UNICANCER
Phase 3 Completed
NCT00006051 2021-02-21
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
UNICANCER
Phase 2 Completed
NCT01566435 2020-10-01
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
Washington University School of Medicine
Phase 2 Completed
NCT00608205 2020-08-06
Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer
Case Comprehensive Cancer Center
Phase 3 Completed
NCT02015650 2020-05-18
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Medical University Innsbruck
Phase 4 Terminated
NCT00721513 2020-04-07
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00468169 2019-10-09
EPIC
University of Chicago
Phase 2 Completed
NCT00462735 2018-03-13
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00052429 2018-01-09
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00352118 2017-12-28
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT01467115 2017-05-09
DREXNECK
Drexel University
Phase 2 Completed
NCT00003582 2016-12-15
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
University of Miami
Phase 1/2 Completed
NCT00580983 2016-09-07
Optimized Intensity Modulated Irradiation for Head and Neck Cancer
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT02047201 2016-03-02
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
Lithuanian University of Health Sciences
Phase 2 Completed
NCT01111942 2015-08-05
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
Southern Illinois University
Phase EARLY_PHASE1 Terminated
NCT02013453 2014-12-02
A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer
University of Michigan Rogel Cancer Center
Phase 2 Withdrawn
NCT00002774 2014-06-20
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Stanford University
Phase 2 Completed
NCT00203905 2014-01-17
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck
University of Chicago
Phase 2 Completed
NCT00095875 2013-11-19
Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)
Dana-Farber Cancer Institute
Phase 3 Completed
NCT00002951 2013-09-05
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
University of Chicago
Phase 2 Completed
NCT00392704 2013-02-22
Treatment of Head & Neck Cancer With Chemotherapy and Radiation
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00352105 2012-11-05
Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer
Case Comprehensive Cancer Center
Phase 1/2 Completed
NCT00910117 2012-02-20
Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Fudan University
Phase 2 Completed
NCT00193284 2010-06-22
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00402545 2009-11-02
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Dana-Farber Cancer Institute
Phase 1 Completed